Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors

Clinical trial NCT00003515 · TERMINATED

Trial details

NCT number: NCT00003515
Sponsor: Burzynski Research Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primitive Neuroectodermal Tumor

Start date: 1996-12-12
Primary completion: 1997-01-03
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.